EP0693121A4 - Anticorps monoclonal 88bv59, subclones et procede de production - Google Patents

Anticorps monoclonal 88bv59, subclones et procede de production

Info

Publication number
EP0693121A4
EP0693121A4 EP95909472A EP95909472A EP0693121A4 EP 0693121 A4 EP0693121 A4 EP 0693121A4 EP 95909472 A EP95909472 A EP 95909472A EP 95909472 A EP95909472 A EP 95909472A EP 0693121 A4 EP0693121 A4 EP 0693121A4
Authority
EP
European Patent Office
Prior art keywords
subclones
making
monoclonal antibody
monoclonal
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95909472A
Other languages
German (de)
English (en)
Other versions
EP0693121A1 (fr
Inventor
Michael G Hanna
Martin V Haspel
Herbert C Hoover
Marie Elena A Fraley
Barry J Kobrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Per Immune Holdings Inc
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of EP0693121A1 publication Critical patent/EP0693121A1/fr
Publication of EP0693121A4 publication Critical patent/EP0693121A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP95909472A 1994-02-04 1995-02-03 Anticorps monoclonal 88bv59, subclones et procede de production Withdrawn EP0693121A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US192089 1988-05-10
US19208994A 1994-02-04 1994-02-04
PCT/US1995/001440 WO1995021244A1 (fr) 1994-02-04 1995-02-03 Anticorps monoclonal 88bv59, subclones et procede de production

Publications (2)

Publication Number Publication Date
EP0693121A1 EP0693121A1 (fr) 1996-01-24
EP0693121A4 true EP0693121A4 (fr) 1999-11-03

Family

ID=22708201

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95909472A Withdrawn EP0693121A4 (fr) 1994-02-04 1995-02-03 Anticorps monoclonal 88bv59, subclones et procede de production

Country Status (7)

Country Link
EP (1) EP0693121A4 (fr)
JP (1) JPH08508893A (fr)
KR (1) KR960701987A (fr)
AU (1) AU698184B2 (fr)
CA (1) CA2158572A1 (fr)
FI (1) FI954700A7 (fr)
WO (1) WO1995021244A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019797A1 (fr) * 1990-06-15 1991-12-26 New York University Heterohybridomes produisant des anticorps monoclonaux humains contre le vih-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828991A (en) * 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
DK0488470T3 (da) * 1990-11-26 1997-12-22 Akzo Nobel Nv Fremgangsmåde til fremstilling af antistoffer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019797A1 (fr) * 1990-06-15 1991-12-26 New York University Heterohybridomes produisant des anticorps monoclonaux humains contre le vih-1

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GLASKY M S ET AL: "STABILITY OF SPECIFIC IMMUNOGLOBIN SECRETION BY EBV-TRANSFORMED LYMPHOBLASTOID CELLS AND HUMAN-MURINE HETEROHYBRIDOMAS", HYBRIDOMA, vol. 8, no. 4, 1 August 1989 (1989-08-01), pages 377 - 389, XP000673899 *
See also references of WO9521244A1 *

Also Published As

Publication number Publication date
FI954700L (fi) 1995-10-03
EP0693121A1 (fr) 1996-01-24
KR960701987A (ko) 1996-03-28
AU698184B2 (en) 1998-10-29
CA2158572A1 (fr) 1995-08-10
FI954700A0 (fi) 1995-10-03
JPH08508893A (ja) 1996-09-24
WO1995021244A1 (fr) 1995-08-10
FI954700A7 (fi) 1995-10-03
AU1742595A (en) 1995-08-21

Similar Documents

Publication Publication Date Title
HU9503638D0 (en) Anti-alpha-v-integrin monoclonal antibody
IL128406A0 (en) Monoclonal antibodies
PL314908A1 (en) Humanised antibodies and their application
ZA949227B (en) Human monoclonal antibodies against human cytokines and methods of making and using such antibodes
EP0870826A4 (fr) Nouvelle proteine et anticorps monoclonal specifique a cette derniere
EP0871393A4 (fr) Immunodetection in situ des antigenes
PL313633A1 (en) Ceramid type compounds, method of obtaining them and their application
IL119816A0 (en) Absorbent structure and method for its manufacture
HUP9702359A3 (en) Monoclonal antibody, method of preparing a monoclonal antibody, and pharmaceutical composition and a diagnostic reagent comprising the monoclonal antibody
EP0767176A4 (fr) Nouveau glyceroglycophospholipide, anticorps contre ce compose et procede de detection de mycoplasme
IL118069A0 (en) Monoclonal antibody reactive to human cetp and assay method for human cetp
AU3923293A (en) Human monoclonal antibodies and methods for human monoclonal antibody production
PL324555A1 (en) Ferrtic steel, method of making same and application thereof
EP0909278A4 (fr) Immunoglobuline g liee a la nephropathie et anticorps contre celle-ci
AU2696495A (en) Method for determining hiv-1 antigen and antibody
PL320610A1 (en) Fragments of monoclonal antibodies of immunosuppressive activity
IL109232A0 (en) Human monoclonal antibodies and processes and materials for making such antibodies
HU9501846D0 (en) Complex material and method for making and application thereof
EP0693121A4 (fr) Anticorps monoclonal 88bv59, subclones et procede de production
AU9143991A (en) Monoclonal antibody op-g2 and method of use
ZA951113B (en) Tumor assosiated monoclonal antibody 123av16
ZA952174B (en) Anti-EGFR single-chain fvs and anti-EGFR antibodies
EP0737829A3 (fr) Joint d'étanchéité ainsi que son procédé de fabrication
EP0520436A3 (en) Monoclonal antibody, method of production thereof and use thereof
GB9506425D0 (en) New uses of monoclonal antibodies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950907

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

111Z Information provided on other rights and legal means of execution

Free format text: AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE * 19981023 AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PERIMMUNE HOLDINGS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 19990916

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000928

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020605